PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site

Press Releases
Within Biotechnology

Press Releases

Submit your press release via PR.com for Free

Receive press releases from companies in this category: By Email RSS Feeds:

PR.com is a leader in paid and free press release distribution. To reach journalists, increase online visibility, and attract new customers, submit via our global online news and press release distribution service to top search engines, thousands of websites, social media, blogger networks, as well as via print, broadcast, radio, mobile channels, and more.

The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human use. - January 15, 2018 - Endoceutics
As DrugCendR is now preparing to transition from a preclinical to a clinical-stage company, the company will present details on their Phase I–ready lead compound CEND-1 – a highly innovative molecular mimicry agent that is able to activate a drug transport mechanism specifically in solid tumors. To date, there are more than 100 studies using DrugCendR’s proprietary technology, providing an unprecedented amount of preclinical validation / proof-of-concept. - January 04, 2018 - DrugCendR
SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group
NuvOx Pharma, a clinical stage biotechnology company, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS). This grant will fund development of a novel syringe sonication device that may... - December 30, 2017 - NuvOx Pharma
Stem Cell Ophthalmology Treatment Study in Florida makes progress treating “untreatable” optic nerve and retinal conditions with publication of positive outcomes. - December 29, 2017 - MD Stem Cells
Single-Use filling assemblies for fill and finish applications in biopharmaceutical and pharmaceutical processing are now available from AdvantaPure. They feature molded connections for seamless fluid flow. Supplied sterilized and ready to install, the assemblies are manufactured with tubing, bags, filters, sterile connectors, filling needles and other accessories specified by the customer. Two tubing materials are offered. - December 21, 2017 - AdvantaPure
Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids
NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids
BioStat Solutions, Inc. today announced that Eloi Kpamegan, Ph.D. has accepted the position of Director, Clinical Operations. - December 14, 2017 - BioStat Solutions, Inc.
A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent compounds... - December 14, 2017 - Cayman Chemical Company
GeneFluidics, a molecular diagnostics company specializing in the development of diagnostics solutions for infectious diseases, today announced CE marking for UtiMax™ under the Directive 98/79/EC on in vitro diagnostic medical devices. UtiMax™has successfully completed a multicenter validation study and clinical testing. It does not require clinical isolates from urine cultures, enabling a rapid ID reporting in as short as 30 minutes and AST in 120 minutes for a positive ID result. - December 10, 2017 - GeneFluidics Inc.
Acquisition continues to grow VistaVu Solutions’ Commitment to SAP Business ByDesign business segment. - December 07, 2017 - BPBD LLC
Arteric Explains How to Uncover Hidden Marketing Insights. - December 06, 2017 - Arteric
RegenLab is attempting to enforce its patent rights against Estar Technologies Ltd., manufacturer of the Eclipse PRP product, Eclipse Aesthetics LLC, a US distributor, as well as their customers. - December 05, 2017 - RegenLab
Arteric Shares Its Practical Approach to Applying AI to Uncover Marketing Insights. - November 27, 2017 - Arteric
Creative BioMart, a global leader in the supply of high quality protein products and efficient protein manufacturing techniques, today announced a major expansion of its Protein Glycosylation Labeling Service capacities as a response to rising customer needs and market demands for characterizing glycan... - November 26, 2017 - Creative Biomart
Healthcare Digital Marketing Agency Shares Strategic and Tactical Insights in a Future-Ready Experience - November 21, 2017 - Arteric
The Asia Microbiota Bank, the first stool bank in Hong Kong, expands the team by adding a new scientist to help lead research efforts on bacteria clusters unique to the Asian population. The scientific team uses next generation sequencing and strain level analysis to optimize Fecal Microbiota Transplantation (FMT) treatment outcomes in Asia. "We hope that the deep FMT data we are collecting from around Asia will help uncover key strains that influence intestinal health."-Co-Founder, Jon Chan - November 16, 2017 - Asia Microbiota Bank
Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence (www.beacon-intelligence.com), to provide clarity to pharma scientists and strategists in the booming immuno-oncology combination field of study. IO Combination Trials Intelligence... - November 16, 2017 - Beacon Intelligence
Cellenkos Inc. has announced a multi-year collaboration with The University of Texas MD Anderson Cancer Center focused on development of cord blood regulatory T cell (CB TREG) therapeutics for treatment of autoimmune disease and inflammatory disorders. As part of this collaboration, Cellenkos Inc. will... - November 15, 2017 - Cellenkos Inc.
Virun® NutraBIOsciences® Prepares to Enter the Finished Product Market with Novel Flavors and Celebrates State Organic Certification. - November 14, 2017 - VIRUN
Endoceutics Inc., a private Quebec City based biopharma company, today announced that the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product IntrarosaTM, intended for the treatment of vulvar... - November 13, 2017 - Endoceutics
Arteric’s President Prepares Healthcare Marketers to Transform Digital Disruption Into Competitive Advantage. - November 08, 2017 - Arteric
Growing market demand for plant-based DHA omega-3 ingredients intersects with innovative food technology. - November 03, 2017 - VIRUN
BPBD adds all4cloud’s eam4cloud and scan4cloud to its new product offerings. - November 02, 2017 - BPBD LLC
MBF Therapeutics, Inc., a clinical stage animal health company developing checkpoint inhibitor vaccines for cancer and infectious diseases, today announced that Thomas Tillett, Chief Executive Officer, will present at the PACT Capital Conference in Philadelphia, PA on Thursday, November 2, 2017 at 9:45am... - November 01, 2017 - MBF Therapeutics Inc
Digital Marketing Thought Leader Prepares Healthcare Marketers for the Next Digital Disruption - October 30, 2017 - Arteric
Clinerion has expanded its geographic coverage to include over 60 million patients in the USA, via a strategic partnership with Provisio Inc. Clinerion now has a truly global footprint for its services for clinical trial patient search and identification, and data generation for real-world evidence and market access activities. - October 30, 2017 - Clinerion
NASA’s James Webb Space Telescope, the replacement to the Hubble Space Telescope is Now Hanging Out in a Vibration-Isolating "Hammock" Supported by Minus K's Negative-Stiffness Vibration Isolators in Johnson Space Center's Vaccum Chamber A being tested. - October 28, 2017 - Minus K Technology Inc.
Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB
NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today FDA 510(k) clearance and full commercial launch of FIBERGRAFT BG Matrix – Bone Graft Substitute for Postero-lateral Spinal Fusion. FIBERGRAFT BG Matrix is the third generation... - October 26, 2017 - Prosidyan, Inc.
Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand. - October 18, 2017 - Batavia Biosciences
Qrons Inc. (OTCPK: QRON) ("Qrons " or the "Company"), a preclinical biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries, announced today the launch of its fully featured website. The website offers... - October 10, 2017 - Qrons Inc.
Global provider of Clinical & Regulatory Affairs consultancy services continues to attract top talent. - October 09, 2017 - G&L Scientific Inc
Digital Marketing Agency Continues Support of Major Healthcare Conference. - October 04, 2017 - Arteric
Adds to Strategic Partnerships across Western and Southern United States - October 04, 2017 - Wake Research Associates
BPBD’s New Pharma Manufacturing Solution Add-On Enables Cloud-Based ERP Solution for Compliance Certification with FDA CFR 21 Part 11 and EU Annex 11 - October 04, 2017 - BPBD LLC
Mapp Biopharmaceutical, Inc., announced today that it has been awarded a Project BioShield contract (HHSO100201700017C) of approximately $46 million by The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the... - September 30, 2017 - Mapp Biopharmaceutical, Inc.
AngioSoma, Inc. (OTC: SOAN) announces Agreement with Esther & Esther, Inc. to maximize sales of its OTC products with existing online marketing platform. Conjunctionally, the company’s subsidiary, Soma Nutraceuticals Inc., completed a licensing agreement with Kentucky-based East Kentucky Organic,... - September 18, 2017 - AngioSoma, Inc.
Cayman Chemical is collaborating with ThermoFisher and HighChem to provide accurate and high quality tandem spectra to the mzCloud™ library of mass data. mzCloud™ is a web-based mass spectral database comprised of a curated collection of high- and low-resolution MSn spectra acquired from... - September 16, 2017 - Cayman Chemical Company
AdvantaPure has launched AdvantaSil High Pressure unreinforced silicone tubing, a product designed to allow for biopharm and pharmaceutical fluid processing at higher flow rates. The tubing offers pressure usage three times that of standard silicone transfer tubing, along with benefits such as limited pumpability up to 30 psi back pressure, full vacuum capabilities on most sizes and better clarity than braided silicone hose. Full BPOG testing is in process. This product is made in USA. - September 15, 2017 - AdvantaPure
Drugshoppe was selected as a finalist in the first annual pitch competition at the Houston Technology Center Innovation Conference and Showcase. Drugshoppe was picked from among many companies that applied in the fields of life sciences, aerospace, energy, IT, and transportation. Drugshoppe will compete... - September 14, 2017 - Drugshoppe
Source Intelligence has released its annual analysis of conflict minerals reports for the 2016 reporting year and despite U.S. government efforts to relax requirements, companies continue to demonstrate increased efforts to minimize sourcing from conflict regions. For direct access to the report, visit:... - September 08, 2017 - Source Intelligence
Project to be Conducted in Collaboration with Brigham and Women’s Hospital, Harvard Medical School. Vascular BioSciences announced today it has an award for a Phase I/II Fast-Track STTR grant in collaboration with Brigham and Women’s Hospital, Harvard Medical School. The STTR Fast-Track... - September 08, 2017 - Vascular BioSciences, Inc
Apostle Inc is pleased to announce the appointment of Dean W. Felsher, MD, PhD as a new member to its Scientific Advisory Board. Dr. Felsher is Professor of Medicine in Departments of Oncology and Pathology at Stanford University School of Medicine. He is Director of Stanford Translational Research and... - September 01, 2017 - Apostle Inc
CPG research team to develop injectable hydrogel technology for eye tamponade. - August 26, 2017 - Cambridge Polymer Group
Rise Up Against Psoriasis Wins Golden Scalpel Award. - August 21, 2017 - Arteric
Company created to market laboratory and scientific equipment from manufacturers worldwide. - August 13, 2017 - Scintica Instrumentation Inc.
BioLabMart Inc., (OTC PINK/Trading Symbol: BLMB) (“the Company”), a startup preclinical stage biotechnology company, is pleased to announce that the company has changed its name to Qrons Inc., and has received a new Committee on Uniform Securities Identification Procedures (CUSIP) number... - August 11, 2017 - Qrons Inc.
Type of Retinitis Pigmentosa responds to stem cells with vision and hearing improvement. - August 11, 2017 - MD Stem Cells
Press Releases 1 - 50 of 2,652 Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
Promote Your Business